Published in Clin Orthop Relat Res on October 01, 2002
Association of a single nucleotide polymorphism in growth differentiate factor 5 with congenital dysplasia of the hip: a case-control study. Arthritis Res Ther (2008) 1.13
The epidemiology and demographics of hip dysplasia. ISRN Orthop (2011) 1.03
Vitamin D and oestrogen receptor polymorphisms in developmental dysplasia of the hip and primary protrusio acetabuli--a preliminary study. J Negat Results Biomed (2007) 0.89
Exclusion of COL2A1 and VDR as developmental dysplasia of the hip genes. Clin Orthop Relat Res (2008) 0.87
The Otto Aufranc Award: Identification of a 4 Mb region on chromosome 17q21 linked to developmental dysplasia of the hip in one 18-member, multigeneration family. Clin Orthop Relat Res (2009) 0.81
A COL2A1 gene polymorphism is related with advanced stages of osteoarthritis of the knee in Mexican Mestizo population. Rheumatol Int (2009) 0.79
Association of oestrogen receptor gene polymorphism with the long-term results of rotational acetabular osteotomy. Int Orthop (2009) 0.75
Comparative in vitro study on the long term performance of cemented hip stems: validation of a protocol to discriminate between "good" and "bad" designs. J Biomech (2003) 1.69
Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol (2012) 1.45
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Res (2009) 1.37
Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene (2002) 1.35
Early diagnosis of ceramic liner fracture. Guidelines based on a twelve-year clinical experience. J Bone Joint Surg Am (2006) 1.25
MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene (2013) 1.20
In vitro testing of a novel limb salvage prosthesis for the distal femur. Clin Biomech (Bristol, Avon) (1998) 1.13
MET overexpression turns human primary osteoblasts into osteosarcomas. Cancer Res (2006) 1.09
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells. Cancer Gene Ther (2002) 1.09
The effect of perineurotomy on nerve regeneration in diabetic rats: how to export it to the clinical setting? Plast Reconstr Surg (2013) 1.08
Sensitivity to implant materials in patients with total knee arthroplasties. Biomaterials (2007) 1.06
Sensitivity to implant materials in patients undergoing total hip replacement. J Biomed Mater Res B Appl Biomater (2006) 1.04
Relationship between obesity and early failure of total knee prostheses. BMC Musculoskelet Disord (2009) 1.03
Xanthoma of bone: first sign of hyperlipidemia type IIB: a case report. Clin Orthop Relat Res (2003) 1.02
Treatment of gingival recession defects with a coronally advanced flap and a xenogeneic collagen matrix: a multicenter randomized clinical trial. J Clin Periodontol (2012) 1.02
Immunological changes in patients with primary osteoarthritis of the hip after total joint replacement. J Bone Joint Surg Br (2003) 1.00
Polylactic acid fibre-reinforced polycaprolactone scaffolds for bone tissue engineering. Biomaterials (2008) 1.00
Factors affecting aseptic loosening of 4750 total hip arthroplasties: multivariate survival analysis. BMC Musculoskelet Disord (2007) 0.98
Does ion release differ between hip resurfacing and metal-on-metal THA? Clin Orthop Relat Res (2008) 0.97
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. J Transl Med (2013) 0.97
V-ATPase is a candidate therapeutic target for Ewing sarcoma. Biochim Biophys Acta (2013) 0.97
Metal-on-metal hip prostheses: correlation between debris in the synovial fluid and levels of cobalt and chromium ions in the bloodstream. Int Orthop (2014) 0.96
The role of hydroxyapatite as solid signal on performance of PCL porous scaffolds for bone tissue regeneration. J Biomed Mater Res B Appl Biomater (2008) 0.96
The combined use of mesenchymal stromal cells and scaffolds for bone repair. Curr Pharm Des (2012) 0.96
A different point of view on sex and risk of hip implant failure and failure rate in women. JAMA Intern Med (2013) 0.95
Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol (2005) 0.95
In vitro wear performance of standard, crosslinked, and vitamin-E-blended UHMWPE. J Biomed Mater Res A (2011) 0.95
The significance of metal staining on alumina femoral heads in total hip arthroplasty. J Arthroplasty (2007) 0.95
Increased osteoclast activity is associated with aggressiveness of osteosarcoma. Int J Oncol (2008) 0.94
Pre-operative diagnosis of infection in total knee arthroplasty: an algorithm. Knee Surg Sports Traumatol Arthrosc (2009) 0.94
Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas. Int J Oncol (2013) 0.93
Osteogenic properties of late adherent subpopulations of human bone marrow stromal cells. Histochem Cell Biol (2009) 0.92
Preparation method and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells. Cytotherapy (2013) 0.92
Investigation on wear of knee prostheses under fixed kinematic conditions. Artif Organs (2008) 0.91
Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts. Biochim Biophys Acta (2011) 0.91
In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells. Int J Cancer (2004) 0.91
Revision of ceramic hip replacements for fracture of a ceramic component: AAOS exhibit selection. J Bone Joint Surg Am (2011) 0.91
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors. J Cell Physiol (2008) 0.90
Gene expression patterns related to osteogenic differentiation of bone marrow-derived mesenchymal stem cells during ex vivo expansion. Tissue Eng Part C Methods (2010) 0.90
Platelet-rich plasma impairs osteoclast generation from human precursors of peripheral blood. J Orthop Res (2010) 0.89
Sex differences in hip morphology: is stem modularity effective for total hip replacement? J Bone Joint Surg Am (2009) 0.89
Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: a cohort study. J Orthop Res (2010) 0.89
Safety of pregnancy and delivery after total hip arthroplasty. J Womens Health (Larchmt) (2007) 0.88
The influence of the centre of rotation on implant survival using a modular stem hip prosthesis. Int Orthop (2008) 0.88
An experimental analogue to model the fibrous tissue layer in cemented hip replacements. J Biomed Mater Res B Appl Biomater (2004) 0.88
Oxidation in ultrahigh molecular weight polyethylene and cross-linked polyethylene acetabular cups tested against roughened femoral heads in a hip joint simulator. Biomacromolecules (2006) 0.88
Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes. Lab Invest (2003) 0.88
Modeling the cost-effectiveness for cement-less and hybrid prosthesis in total hip replacement in Emilia Romagna, Italy. J Surg Res (2009) 0.88
Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors. Acta Orthop (2011) 0.88
Wear behaviour of cross-linked polyethylene assessed in vitro under severe conditions. Biomaterials (2005) 0.87
Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma. Anticancer Res (2007) 0.87
Ceramic-on-metal for total hip replacement: mixing and matching can lead to high wear. Artif Organs (2010) 0.87
Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells. Int J Cancer (2008) 0.87
V-ATPase as an effective therapeutic target for sarcomas. Exp Cell Res (2014) 0.87
Isolation, characterisation and osteogenic potential of human bone marrow stromal cells derived from the medullary cavity of the femur. Chir Organi Mov (2008) 0.87
Is wear debris responsible for failure in alumina-on-alumina implants? Acta Orthop (2009) 0.87
Modular neck prostheses in DDH patients: 11-year results. J Orthop Sci (2011) 0.86
Insulin receptor isoforms are differently expressed during human osteoblastogenesis. Differentiation (2012) 0.86
Synovial fluid microanalysis allows early diagnosis of ceramic hip prosthesis damage. J Orthop Res (2012) 0.86
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate. Biomaterials (2008) 0.85
Histogenetic characterization of giant cell tumor of bone. Clin Orthop Relat Res (2008) 0.85
Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials (2005) 0.85
Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis. J Bone Joint Surg Am (2006) 0.85
Brucella infection in total knee arthroplasty. Case report and revision of the literature. Chir Organi Mov (2008) 0.84
IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors. Exp Cell Res (2011) 0.84
Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14(+) cells of giant cell tumor of bone. Am J Pathol (2013) 0.84
Pathological dislocation of the hip in neurofibromatosis: a case report. Chir Organi Mov (2008) 0.84
Serum ion levels after ceramic-on-ceramic and metal-on-metal total hip arthroplasty: 8-year minimum follow-up. J Orthop Res (2008) 0.84
A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. Nanomedicine (Lond) (2009) 0.84
Enhancing osteoconduction of PLLA-based nanocomposite scaffolds for bone regeneration using different biomimetic signals to MSCs. Int J Mol Sci (2012) 0.84
Risk factors for ceramic liner fracture after total hip arthroplasty. Hip Int (2012) 0.84
Osteon classification in human fibular shaft by circularly polarized light. Cells Tissues Organs (2009) 0.84
Inhibition of angiogenic activity of renal carcinoma by an antisense oligonucleotide targeting fibroblast growth factor-2. Anticancer Res (2005) 0.83
Long-term results of total hip replacement in patients with Legg-Calvé-Perthes disease. J Bone Joint Surg Am (2011) 0.83